FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

104 letters match. Newest first.

  1. Matthew 7:25 Inc dba Thrive Pharmacy

    FDA says Thrive Pharmacy compounded drugs without valid prescriptions and released subpotent buprenorphine troches, making them adulterated and misbranded.

    High risk
  2. Magnolia Medical Technologies, Inc.

    Magnolia Medical Technologies received an FDA warning letter for current good manufacturing practice violations affecting its Steripath Gen 2 blood collection system.

    Medium
  3. Novel Laboratories, Inc. d.b.a LUPIN

    FDA warned Lupin's Novel Laboratories over manufacturing violations including equipment cross-contamination and unvalidated temazepam capsules.

    High risk
  4. Honest Globe, Inc.

    FDA cited Honest Globe for manufacturing-quality failures and for selling unapproved CBD pain-relief drugs.

    High risk